Biofrontera Inc. announces preliminary product revenues for the First Quarter of 2022. Product revenues for the first quarter of 2022 are anticipated to be in the range of approximately $9.5 million to $10.0 million, representing an increase of approximately 102% to 113% compared with the first quarter of 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 USD | -0.01% | -5.84% | -62.10% |
May. 16 | Transcript : Biofrontera Inc., Q1 2024 Earnings Call, May 16, 2024 | |
May. 15 | Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.10% | 5.34M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+12.98% | 238B | |
+6.96% | 204B | |
-6.50% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- BFRI Stock
- News Biofrontera Inc.
- Biofrontera Inc. Announces Preliminary Product Revenues for the First Quarter of 2022